Literature DB >> 19778055

Microwave-assisted Ullmann C-S bond formation: synthesis of the P38alpha MAPK clinical candidate VX-745.

Mark C Bagley1, Terence Davis, Matthew C Dix, Vincenzo Fusillo, Morgane Pigeaux, Michal J Rokicki, David Kipling.   

Abstract

Microwave irradiation promotes the rapid and efficient reaction of a thiophenol and aryl or heteroaryl halide using a copper or palladium catalyst and a range of ligands, depending upon substrate. Of particular utility is the use of copper(I) iodide (5 mol %) and trans-cyclohexane-1,2-diol as ligand under basic conditions and microwave irradiation to give the corresponding sulfide in high yield. This method for C-S bond formation is applied in the four-step synthesis of the clinical candidate VX-745 in 38% overall yield. The inhibitory activity of VX-745 against p38alpha MAPK is confirmed in Werner syndrome dermal fibroblasts at 1.0 microM concentration by immunoblot assay.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19778055     DOI: 10.1021/jo9017155

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  6 in total

1.  Facile synthesis of glycosylated Fmoc amino acid building blocks assisted by microwave irradiation.

Authors:  Nianhuan Yao; Gabriel Fung; Hamed Malekan; Long Ye; Mark J Kurth; Kit S Lam
Journal:  Carbohydr Res       Date:  2010-08-02       Impact factor: 2.104

2.  Synthesis of 5,7-disubstituted-4-methyl-7H-pyrrolo[2,3-d]pyrimidin-2-amines as microtubule inhibitors.

Authors:  Aleem Gangjee; Sonali Kurup; Charles D Smith
Journal:  Bioorg Med Chem       Date:  2013-01-03       Impact factor: 3.641

3.  RECENT SYNTHETIC DEVELOPMENTS AND APPLICATIONS OF THE ULLMANN REACTION. A REVIEW.

Authors:  Hao Lin; Dianqing Sun
Journal:  Org Prep Proced Int       Date:  2013       Impact factor: 1.628

4.  Microwave-Assisted Synthesis of a MK2 Inhibitor by Suzuki-Miyaura Coupling for Study in Werner Syndrome Cells.

Authors:  Mark C Bagley; Mohammed Baashen; Irina Chuckowree; Jessica E Dwyer; David Kipling; Terence Davis
Journal:  Pharmaceuticals (Basel)       Date:  2015-06-03

Review 5.  Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome.

Authors:  Mark C Bagley; Terence Davis; Paola G S Murziani; Caroline S Widdowson; David Kipling
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-04

6.  Copper-catalyzed cyanothiolation to incorporate a sulfur-substituted quaternary carbon center.

Authors:  Yubing Huang; Xianwei Li; Xu Wang; Yue Yu; Jia Zheng; Wanqing Wu; Huanfeng Jiang
Journal:  Chem Sci       Date:  2017-08-15       Impact factor: 9.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.